Life Sciences

Company Profile

Scioto Biosciences is a preclinical stage company developing innovative therapies devoted to having a transformative impact on the delivery of microbiome therapeutics. The Scioto Platform has the potential to enhance efficacy wherever probiotics are used.

Scioto Biosciences in the News

Scioto Biosciences: Fortune Term Sheet — Tuesday, May 22
Fortune Term Sheet
Nationwide Children’s Spinoff Fighting Infection in Premature Babies Raises $1.8M
Columbus Business First